Literature DB >> 35464284

Nonalcoholic fatty liver disease in early life and all-cause and cause-specific mortality.

Donghee Kim1, Aijaz Ahmed1.   

Abstract

Entities:  

Year:  2022        PMID： 35464284      PMCID： PMC9023838          DOI： 10.21037/hbsn-21-571

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  10 in total

1.  Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality.

Authors:  Donghee Kim; Luis Miguel Vazquez-Montesino; Jessica A Escober; Christopher T Fernandes; George Cholankeril; Rohit Loomba; Stephen A Harrison; Zobair M Younossi; Aijaz Ahmed
Journal:  Am J Gastroenterol       Date:  2020-06-03       Impact factor: 10.864

Review 2.  Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.

Authors:  Parambir S Dulai; Siddharth Singh; Janki Patel; Meera Soni; Larry J Prokop; Zobair Younossi; Giada Sebastiani; Mattias Ekstedt; Hannes Hagstrom; Patrik Nasr; Per Stal; Vincent Wai-Sun Wong; Stergios Kechagias; Rolf Hultcrantz; Rohit Loomba
Journal:  Hepatology       Date:  2017-03-31       Impact factor: 17.425

3.  Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016.

Authors:  Donghee Kim; Won Kim; Adeyinka C Adejumo; George Cholankeril; Sean P Tighe; Robert J Wong; Stevan A Gonzalez; Stephen A Harrison; Zobair M Younossi; Aijaz Ahmed
Journal:  Hepatol Int       Date:  2019-01-29       Impact factor: 6.047

4.  Global burden of NAFLD and chronic liver disease among adolescents and young adults.

Authors:  James M Paik; Khaled Kabbara; Katherine E Eberly; Youssef Younossi; Linda Henry; Zobair M Younossi
Journal:  Hepatology       Date:  2021-12-21       Impact factor: 17.298

5.  The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years.

Authors:  A E Feldstein; P Charatcharoenwitthaya; S Treeprasertsuk; J T Benson; F B Enders; P Angulo
Journal:  Gut       Date:  2009-07-21       Impact factor: 23.059

6.  Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States.

Authors:  Donghee Kim; Andrew A Li; Brandon J Perumpail; Chiranjeevi Gadiparthi; Won Kim; George Cholankeril; Jeffrey S Glenn; Stephen A Harrison; Zobair M Younossi; Aijaz Ahmed
Journal:  Hepatology       Date:  2019-02-11       Impact factor: 17.425

7.  Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.

Authors:  Donghee Kim; W Ray Kim; Hwa Jung Kim; Terry M Therneau
Journal:  Hepatology       Date:  2013-01-25       Impact factor: 17.425

8.  Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States.

Authors:  Donghee Kim; Peter Konyn; Keeryth K Sandhu; Brittany B Dennis; Amanda C Cheung; Aijaz Ahmed
Journal:  J Hepatol       Date:  2021-08-08       Impact factor: 30.083

9.  Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality.

Authors:  Tracey G Simon; Bjorn Roelstraete; Kayla Hartjes; Uzma Shah; Hamed Khalili; Henrik Arnell; Jonas F Ludvigsson
Journal:  J Hepatol       Date:  2021-07-03       Impact factor: 25.083

Review 10.  Recent Epidemiology of Nonalcoholic Fatty Liver Disease.

Authors:  Soumya Murag; Aijaz Ahmed; Donghee Kim
Journal:  Gut Liver       Date:  2021-03-15       Impact factor: 4.519
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.